About
Christopher Nabel is a medical oncologist and researcher at MIT's Koch Institute. His interdisciplinary work explores how cancer metabolism drives immunotherapy resistance, focusing on adenosine accumulation in tumor microenvironments.
He develops computational models of metabolic pathways that suppress immune responses, seeking pharmacological interventions to restore anti-tumor immunity. His approach combines molecular biology with clinical informatics.
Recent studies examine spatial accessibility to healthcare in resource-limited settings and spatiotemporal patterns of COVID-19 hospitalization.
He collaborates with Massachusetts General Hospital on translational oncology projects.
0Publications listed
Find Chris Nabel elsewhere
Related Searches
You Might Also Like
Alisha Holtzhausen HanksUniversity of North Carolina at Chapel Hill · Assistant Professor
Inmaculada Martínez ReyesGerman Cancer Research Center · Assistant Professor- JJeremy B. JacoxYale University · Academic
Tobiloba OniMassachusetts Institute of Technology · Research Fellow- IIlaria EliaKU Leuven · Assistant Professor
Yonghong WanMcMaster University · Professor